1 AUGUST

NEW ZEALAND GAZETTE

2429

Dated this 24th day of July 2002.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go5043

Classification of Medicines

Pursuant to section 106 (1) of the Medicines Act 1981, I, G. R. Boyd, Chief Advisor, Safety and Regulation, acting under delegated authority, hereby declare the following:

1. The medicines listed in Schedule 1 to this notice are classified as prescription medicines.
2. The medicines listed in Schedule 2 to this notice are classified as restricted medicines.
3. The medicines listed in Schedule 3 to this notice are classified as pharmacy-only medicines.

Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.

Unless specific reference is made otherwise, every reference applies also to medicines that are:

(a) preparations and admixtures containing any proportion of any substance listed in the notice.

(b) salts and esters of any substance listed in the notice.

(c) preparations or extracts of biological materials listed in the notice.

(d) salts or oxides of elements listed in the notice.

Unless specific reference is made otherwise, every reference to a medicine applies:

(i) if the medicine is in an injection or eye preparation, to any concentration of that medicine; and

(ii) if the medicine is not in an injection or eye preparation, only if the concentration of the medicine or the concentration of the total active principles of the medicine is greater than 10 milligrams per litre or per kilogram.

Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.

Schedule 1

Prescription Medicines

Acepromazine

Adenosine; for injection

Amethocaine; for internal use; for external use in medicines containing more than 10%; for ophthalmic use except when used in practice by a registered optometrist

Amylocaine

Aristolochic acid; at all strengths

Atomoxetine

Atropa belladonna; except when specified elsewhere in the Schedule

Atropine; except when specified elsewhere in the Schedule; except when used as an antidote in a device designed for self-injection; except in medicines containing 100 micrograms or less per litre or per kilogram

Atropine methonitrate

Benorylate

Benzocaine; for internal use; for external use in medicines containing more than 10%

Benzydamine; for internal use

Bexarotene

Butacaine

Butyl aminobenzoate; except in medicines for dermal use containing 2% or less

Cinchocaine; for ophthalmic use; for external use in medicines containing more than 0.5%

Clindamycin

Colestyramine

Darbepoetin

Datura spp; except for oral use when specified elsewhere in the Schedule; except in datura stramonium or datura tatula for smoking or burning

Dextrorphan

Dicyclomine

Digoxin-specific antibody fragment

Diperodon

Drotrecogin

Duboisia leichhardtii; except when specified elsewhere in the Schedule

Duboisia myoporides; except when specified elsewhere in the Schedule

Ephedra spp

Etidocaine

Ezetimibe

Folic acid; for injection

Folinic acid; for injection

Glatiramer acetate

Guaiphenesin; except for oral use in medicines containing 2% or less or 200 milligrams or less

Homatropine

Hyoscine; except when specified elsewhere in the Schedule

Hyoscine butylbromide; except when specified elsewhere in the Schedule

Hyoscyamine; except when specified elsewhere in the Schedule

Hyoscyamus niger; except when specified elsewhere in the Schedule

Hypromellose; for injection

Insulins

Levetiracetam

Levosimendan

Lignocaine; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for ophthalmic use except when used in practice by a registered optometrist; for injection except when used as a local anaesthetic in practice by a registered nurse or podiatrist or by a dental therapist; for external use in medicines containing more than 10%

Nicoumalone

Nitrofurazone

Nux vomica

Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin

Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin

Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%

Pramocaine

Pregnenolone